| 13.30 |
Networking buffet lunch |
|
| 14.30 |
Introduction |
Dr Julie Deacon (MNT Network) |
| 14.35 |
Micro & Nanofluidic Technologies for Drug Discovery |
Brian Warrington (GlaxoSmithKline) |
| 14.50 |
Challenges for Targeted Drug Delivery |
D. Hatrick (PA Consulting) |
| 15.05 |
Commercialisation Challenges for Nanotechnology in Regenerative Medicine |
Christina Doyle (Xeno Medical) |
| 15.20 |
Refreshments. ( Opportunity for networking)
|
|
| 15.45 |
Nano-chemical Approaches to Controlled and Targeted Drug Delivery |
Marie-Clare Parker (XtalBio)
|
| 16.00 |
Current Developments in Micro- and Nano-medical Diagnostics
|
David Williams (Unipath) |
| 16.15 |
Cardiac Risk Panel Diagnostics |
Lindy Murphy (Oxford Biosensors) |
| 16.30 |
Open Forum/Discussion:
“Exploiting Nano-Medicine: Technology Push or Demand Pull?”
|
Speakers |
| 17.25 |
Closing Comments - followed by refreshments and opportunity for further networking |
Dr Julie Deacon (MNT Network) |